全球眼表疾病市場（2023）：研究報告

該報告基於對美國和西歐的眼科醫生和驗光師的調查（2023年7月），提供了接受眼表疾病檢查和測試的患者的趨勢、治療方法的採用狀況以及最新信息. 我們編譯並提供有關市場趨勢的知識等資訊。

我們邀請在 Market-Scope.com 自行註冊的大多數專業（白內障、屈光、角膜、青光眼、普通科）的從業者參加我們贊助的年度眼表疾病調查。

研究報告只是對所報告數據的總結分析，並未對整個市場做出任何額外的假設。所有調查資料均經過去識別化處理並儲存在安全伺服器上。

分析內容

調查問題由 Market Scope 與調查贊助商合作制定。問題包括但不限於：

• 眼表疾病的類型
• 乾眼症的嚴重程度和病理學
• 過敏性結膜炎的治療
• 用於評估眼表疾病的診斷劑
• 用於治療乾眼症的眼藥水和藥物
• 用於乾眼症的醫療設備和替代療法
• 生物製品的使用

Market Scope surveyed ophthalmologists and optometrists in the United States and Western Europe during July 2023 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends.

Practitioners from most specialties (cataract, refractive, cornea, glaucoma, and comprehensive) who self-registered on Market-Scope.com were invited to participate in an annual sponsored survey on ocular surface disease.

An email invitation was sent on July 7, 2023, and last call invitations on July 14 and July 21, 2023. We received 169 total complete, unique responses - 130 from the US and 39 from Western Europe. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey.

Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server.

Contents:

Questions included in the survey were developed by Market Scope in combination with companies that sponsor the survey. Question topics included, but were not limited to, the following:

• Types of ocular surface disease prevalence
• Dry eye severity and pathology
• Allergic conjunctivitis treatments
• Diagnostics used to evaluate ocular surface disease
• Drops and pharmaceuticals used to treat dry eye
• Devices and alternative treatments used for dry eye
• Biologics use